查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1503308

到 2030 年弱視市場預測：按類型、診斷、治療、應用和地區分類的全球分析

Lazy Eye Market Forecasts to 2030 - Global Analysis By Type, Diagnosis, Treatment, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球低視力市場規模為 32.6 億美元，預計到 2030 年將達到 49.2 億美元，預測期內複合年成長率為 7.1%。

當一個人戴著處方眼鏡或隱形眼鏡無法達到正常視力時，就會出現一種稱為弱視的發展性視力障礙。它通常始於兒童時期，當時眼睛和大腦仍在發育。弱視是一種大腦偏愛一隻眼睛而不是另一隻眼睛的疾病，導致受影響眼睛的視力下降。其他常見原因包括眼睛屈光不正的顯著差異、斜視（眼睛錯位）以及其他影響眼睛的疾病，例如白內障。

根據美國眼科學會的數據，弱視（俗稱忽視）是兒童視力喪失最常見的原因，在美國每 100 名兒童中約有 2 至 3 人受到影響。

弱視病例增加

由於多種因素，包括遺傳傾向、出生率上升以及螢幕使用和戶外活動減少等環境因素，弱視在世界各地變得越來越普遍。鑑於盛行率不斷增加，有效的診斷和管理方法至關重要。如果不及時治療，弱視可能會導致永久性視力障礙，因此早期發現至關重要。此外，隨著醫療保健提供者努力解決這一常見問題，對治療解決方案的需求不斷增加，推動市場成長。

最先進治療的價格過高

該市場成長的主要障礙之一是先進弱視治療的高成本，例如數位治療系統和專門的矯正鏡片。最終用戶必須為許多尖端解決方案支付高額成本，這是由於其研發、生產和行銷相關的高成本。沒有足夠醫療保險的家庭或生活在低收入地區的人可能會感到這種經濟負擔尤其沉重。此外，由於這個原因，這些治療方法的成本仍然是各個社會經濟群體採用和利用這些治療方法的主要障礙。

新興市場的成長

弱視治療市場在新興經濟體有著巨大的擴張潛力。拉丁美洲、亞洲和非洲國​​家都在經歷經濟成長，並正在發展醫療基礎設施。隨著對眼睛健康問題的了解和可支配收入的增加，對有效弱視治療的需求也增加。此外，對於有意進入這些市場的公司來說，很大程度上開拓的消費群可能是一個優勢。

患者依從性問題

成功的弱視治療最重要的方面之一是患者的依從性。許多治療方法，例如阿托品眼藥水和眼貼，必須長期持續使用才能有效。然而，患者的依從性很難維持，特別是當患者年輕並且可能對某些治療方法感到不舒服或受到恥辱時。此外，違規從可能導致治療結果不理想、降低治療效果並增加退出率。需要解決合規問題，以提高治療效果和市場永續性。

COVID-19 的影響：

由於醫療保健服務中斷以及常規眼科檢查和治療的延誤，COVID-19 的爆發對弱視治療市場產生了重大影響。鎖上門和其他保持社交距離的策略減少了患者去看眼科醫師的次數，往往會延遲弱視的早期發現和治療。此外，由於疫情帶來的經濟負擔和經濟不安全感，一些家庭沒有優先考慮非緊急醫療保健，包括低視力治療。

斜視場預計在預測期間內最大

斜視弱視領域在斜視（弱視）市場佔有率最大。由於眼睛錯位（稱為斜視），斜視性弱視是最常見的弱視類型。為了防止雙眼視覺，大腦會優先考慮一隻眼睛而不是另一隻眼睛，從而導致未對準的眼睛的視覺發育不良。早期診斷和治療對於調整眼睛和改善視力至關重要。此外，這些手術通常涉及使用眼罩、矯正眼鏡或手術。

預計在預測期內，篩檢領域的複合年成長率最高。

斜視（弱視）市場的照片篩檢部分預計將以最高複合年成長率成長。照片篩檢涉及使用專用的相機和軟體為孩子的眼睛拍照。分析這些影像以查找弱視的危險因素，例如斜視和屈光不正。這種方法特別有益，因為它快速、非侵入性且易於使用，即使對於不配合傳統眼科檢查的幼兒也是如此。此外，由於多種因素，該市場正在迅速擴大，包括兒科篩檢的普及、照片篩檢技術的進步以及對早期檢測價值的日益了解。

佔比最大的地區：

北美，尤其是美國，由於先進的醫療保健系統、較高的認知度和易於獲得的治療方案而在弱視市場中佔據主導地位。由於失智症在美國非常普遍，因此有一個健康的市場，得到強大的製藥公司、受人尊敬的研究設施以及治療視力喪失的積極方法的支持。此外，該國在北美盲眼市場的巨大市場佔有率歸因於其對醫療保健創新和治療方式的廣泛可用性的關注。

複合年成長率最高的地區：

中國、日本和印度等亞太地區的複合年成長率最高。醫療保健成本上升、公眾對眼科疾病的認知不斷提高以及獲得醫療保健的便利性（尤其是在農村地區）等因素正在推動這一成長。此外，中國和印度等國家由於人口眾多、弱視病例不斷增加以及注重發展醫療基礎設施，預計將顯著成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球低視力市場：依類型

  • 斜視
  • 屈光弱視
  • 形覺剝奪性弱視
  • 屈光參差性弱視
  • 閉塞性弱視
  • 其他類型

第6章全球弱視市場：依診斷

  • 斜視測試
  • 一般眼科檢查
  • 視力檢查
  • 照片篩檢
  • 布魯克納測試

第7章全球弱視市場：依治療分類

  • 矯正眼鏡
    • 隱形眼鏡
    • 眼鏡
  • 外科手術
  • 眼罩
  • 阿托品眼藥水
  • 電玩遊戲
  • 其他治療方法

第8章全球低視力市場：依應用分類

  • 醫院
  • 專科診所
  • 零售藥房
  • 眼科診所
  • 其他應用

第9章全球低視力市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Johnson And Johnson Services, Inc
  • Golden Vision
  • Krafty Eye Patches
  • Adwia Pharmaceuticals
  • NovaSight
  • 3M
  • Pfizer Inc
  • TCI Chemicals Pvt. Ltd
  • Rebion
  • Bausch & Lomb Incorporated
  • Opthopatch
  • Vivid Vision, Inc
  • Hilco Vision
  • Walgreens
  • Fresnel Prism & Lens
Product Code: SMRC26474

According to Stratistics MRC, the Global Lazy Eye Market is accounted for $3.26 billion in 2024 and is expected to reach $4.92 billion by 2030 growing at a CAGR of 7.1% during the forecast period. A vision development disorder known as lazy eye, or amblyopia, occurs when one eye is unable to achieve normal visual acuity, even with prescription eyeglasses or contact lenses. It usually begins in childhood, when the eyes and brain are still growing. Amblyopia is a condition in which the brain prefers one eye over the other, impairing vision in the affected eye. Moreover, common causes include significant differences in the prescription (refractive error) between the two eyes, strabismus (misalignment of the eyes), or other conditions affecting the eyes, such as cataracts.

According to the American Academy of Ophthalmology, amblyopia, commonly known as lazy eye, is the most common cause of visual impairment in children, affecting approximately 2 to 3 out of every 100 children in the United States.

Market Dynamics:

Driver:

Growing number of amblyopia cases

Due to a number of factors, including genetic predispositions, rising birth rates, and environmental factors like screen time and fewer outdoor activities, amblyopia is becoming more commonplace worldwide. An efficient diagnosis and management approach is imperative in light of this increasing prevalence. It is imperative to detect amblyopia early on because, if left untreated, it can cause permanent visual impairments. Moreover, as healthcare providers strive to address this prevalent condition, the demand for treatment solutions is growing, driving market growth.

Restraint:

Exorbitant price of cutting-edge therapies

One major obstacle to the growth of this market is the high cost of advanced amblyopia treatments, such as digital therapy systems and specialty corrective lenses. The high costs that end users must pay for many of these cutting-edge solutions stem from the significant costs associated with their R&D, production, and marketing. Families without sufficient health insurance or those residing in low-income areas may find this financial burden especially difficult. Additionally, because of this, the cost of these treatments continues to be a major barrier to their adoption and accessibility by a variety of socioeconomic groups.

Opportunity:

Growth in emerging markets

There is a big chance for the market for amblyopia treatments to expand in emerging economies. Latin American, Asian, and African nations are all seeing increases in their economies, as well as improvements to their infrastructure for healthcare. The demand for efficient amblyopia treatments is raising as knowledge of eye health issues and disposable incomes both rise. Furthermore, a largely unexplored consumer base can be advantageous to businesses that deliberately enter these markets.

Threat:

Problems with Patient Compliance

One of the most important aspects of amblyopia treatment success is patient compliance. For many treatment modalities, like atropine drops and eye patches, to be effective, they must be used consistently over an extended period of time. But it can be difficult to keep patients compliant, particularly when they are young and may find certain treatments upsetting or stigmatizing. Moreover, non-compliance may result in less than ideal treatment results, which may lower the treatments' perceived efficacy and possibly increase the dropout rate. Improving the effectiveness of treatment and the sustainability of the market require addressing compliance issues.

Covid-19 Impact:

Due to disruptions in healthcare services and delays in routine eye examinations and treatments, the COVID-19 pandemic had a significant effect on the amblyopia treatment market. Lockdowns and other social distancing tactics decreased patient visits to ophthalmologists, which in many cases delayed the early detection and treatment of amblyopia. Additionally, some families deprioritized non-emergency healthcare, including treatment for amblyopia, due to financial strain and economic uncertainty brought on by the pandemic.

The Strabismic segment is expected to be the largest during the forecast period

The Strabismic Amblyopia segment has the largest market share in lazy eye (amblyopia). As a result of an eye misalignment known as strabismus, strabismic amblyopia is the most prevalent type of amblyopia. Poor visual development in the misaligned eye results from the brain favoring one eye over the other to prevent double vision. In order to align the eyes and improve vision, early diagnosis and treatment are essential. Furthermore, these procedures frequently involve the use of eye patches, corrective glasses, or surgery.

The Photo screening segment is expected to have the highest CAGR during the forecast period

The photo screening segment of the lazy eye (amblyopia) market is anticipated to grow at the highest CAGR. Photo screening is taking pictures of a child's eyes with specialized cameras and software. These images are then analyzed to find amblyopia risk factors like strabismus or refractive errors. Because it is quick, non-invasive, and simple to use on young children who might not cooperate for traditional eye exams, this method is especially beneficial. Moreover, this market is expanding quickly due to a number of factors, including increased adoption of pediatric screenings, photo screening technology advancements, and a growing understanding of the value of early detection.

Region with largest share:

Due to its sophisticated healthcare system, high awareness, and easy access to treatment options, North America-and especially the United States-dominate the market for lazy eyes. Because lazy eye cases are so common in the US, there is a healthy market there that is backed by strong pharmaceutical companies, esteemed research facilities, and a proactive approach to treating vision disorders. Additionally, the nation's notable market share in the North American lazy eye market can be attributed to its focus on healthcare innovation and the extensive accessibility of treatment modalities.

Region with highest CAGR:

The lazy eye market has the highest CAGR in the Asia-Pacific region, which includes nations like China, Japan, and India. Factors like rising healthcare costs, increased public awareness of eye conditions, and easier access to healthcare, especially in rural areas, are driving this growth. Furthermore, with their sizable populations, nations like China and India present substantial growth prospects because of the increased incidence of lazy eye cases and the increased attention being paid to the development of healthcare infrastructure.

Key players in the market

Some of the key players in Lazy Eye market include Johnson And Johnson Services, Inc, Golden Vision, Krafty Eye Patches, Adwia Pharmaceuticals, NovaSight, 3M, Pfizer Inc, TCI Chemicals Pvt. Ltd, Rebion, Bausch & Lomb Incorporated, Opthopatch, Vivid Vision, Inc, Hilco Vision, Walgreens and Fresnel Prism & Lens.

Key Developments:

In May 2024, Johnson & Johnson has entered into a definitive agreement to acquire Proteologix Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with potential for an additional milestone payment.

In January 2024, 3M Health Care announced that its Medical Solutions Division received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity. The award enables 3M to develop a range of new solutions for infection prevention, wound management and wound healing.

In September 2023, Bausch + Lomb Corporation, a subsidiary of Bausch Health Companies Inc. announced it has completed its acquisition of XIIDRA(R) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.

Types Covered:

  • Strabismic
  • Refractive Amblyopia
  • Deprivation Amblyopia
  • Anisometropia Amblyopia
  • Reverse Amblyopia
  • Other Types

Diagnosis Covered:

  • Squint Test
  • General Eye Test
  • Visual Acuity Tests
  • Photo Screening
  • Bruckner Test

Treatments Covered:

  • Corrective Eyewear
  • Surgery
  • Eye Patches
  • Atropine Eye Drops
  • Video Game
  • Other Treatments

Applications Covered:

  • Hospitals
  • Specialty Clinics
  • Retail Pharmacies
  • Eye Care Clinics
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lazy Eye Market, By Type

  • 5.1 Introduction
  • 5.2 Strabismic
  • 5.3 Refractive Amblyopia
  • 5.4 Deprivation Amblyopia
  • 5.5 Anisometropia Amblyopia
  • 5.6 Reverse Amblyopia
  • 5.7 Other Types

6 Global Lazy Eye Market, By Diagnosis

  • 6.1 Introduction
  • 6.2 Squint Test
  • 6.3 General Eye Test
  • 6.4 Visual Acuity Tests
  • 6.5 Photo Screening
  • 6.6 Bruckner Test

7 Global Lazy Eye Market, By Treatment

  • 7.1 Introduction
  • 7.2 Corrective Eyewear
    • 7.2.1 Contact Lenses
    • 7.2.2 Glasses
  • 7.3 Surgery
  • 7.4 Eye Patches
  • 7.5 Atropine Eye Drops
  • 7.6 Video Game
  • 7.7 Other Treatments

8 Global Lazy Eye Market, By Application

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Specialty Clinics
  • 8.4 Retail Pharmacies
  • 8.5 Eye Care Clinics
  • 8.6 Other Applications

9 Global Lazy Eye Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Johnson And Johnson Services, Inc
  • 11.2 Golden Vision
  • 11.3 Krafty Eye Patches
  • 11.4 Adwia Pharmaceuticals
  • 11.5 NovaSight
  • 11.6 3M
  • 11.7 Pfizer Inc
  • 11.8 TCI Chemicals Pvt. Ltd
  • 11.9 Rebion
  • 11.10 Bausch & Lomb Incorporated
  • 11.11 Opthopatch
  • 11.12 Vivid Vision, Inc
  • 11.13 Hilco Vision
  • 11.14 Walgreens
  • 11.15 Fresnel Prism & Lens

List of Tables

  • Table 1 Global Lazy Eye Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Lazy Eye Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Lazy Eye Market Outlook, By Strabismic (2022-2030) ($MN)
  • Table 4 Global Lazy Eye Market Outlook, By Refractive Amblyopia (2022-2030) ($MN)
  • Table 5 Global Lazy Eye Market Outlook, By Deprivation Amblyopia (2022-2030) ($MN)
  • Table 6 Global Lazy Eye Market Outlook, By Anisometropia Amblyopia (2022-2030) ($MN)
  • Table 7 Global Lazy Eye Market Outlook, By Reverse Amblyopia (2022-2030) ($MN)
  • Table 8 Global Lazy Eye Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 9 Global Lazy Eye Market Outlook, By Diagnosis (2022-2030) ($MN)
  • Table 10 Global Lazy Eye Market Outlook, By Squint Test (2022-2030) ($MN)
  • Table 11 Global Lazy Eye Market Outlook, By General Eye Test (2022-2030) ($MN)
  • Table 12 Global Lazy Eye Market Outlook, By Visual Acuity Tests (2022-2030) ($MN)
  • Table 13 Global Lazy Eye Market Outlook, By Photo Screening (2022-2030) ($MN)
  • Table 14 Global Lazy Eye Market Outlook, By Bruckner Test (2022-2030) ($MN)
  • Table 15 Global Lazy Eye Market Outlook, By Treatment (2022-2030) ($MN)
  • Table 16 Global Lazy Eye Market Outlook, By Corrective Eyewear (2022-2030) ($MN)
  • Table 17 Global Lazy Eye Market Outlook, By Contact Lenses (2022-2030) ($MN)
  • Table 18 Global Lazy Eye Market Outlook, By Glasses (2022-2030) ($MN)
  • Table 19 Global Lazy Eye Market Outlook, By Surgery (2022-2030) ($MN)
  • Table 20 Global Lazy Eye Market Outlook, By Eye Patches (2022-2030) ($MN)
  • Table 21 Global Lazy Eye Market Outlook, By Atropine Eye Drops (2022-2030) ($MN)
  • Table 22 Global Lazy Eye Market Outlook, By Video Game (2022-2030) ($MN)
  • Table 23 Global Lazy Eye Market Outlook, By Other Treatments (2022-2030) ($MN)
  • Table 24 Global Lazy Eye Market Outlook, By Application (2022-2030) ($MN)
  • Table 25 Global Lazy Eye Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 26 Global Lazy Eye Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 27 Global Lazy Eye Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 28 Global Lazy Eye Market Outlook, By Eye Care Clinics (2022-2030) ($MN)
  • Table 29 Global Lazy Eye Market Outlook, By Other Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.